American Medical Technologies Inc. (ADLI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2007 | -963.95 Thousand USD | 33.53% |
| 2006 | -1.52 Million USD | -9.83% |
| 2005 | -1.54 Million USD | 52.64% |
| 2004 | -1.67 Million USD | 36.43% |
| 2003 | -3.73 Million USD | -9.9% |
| 2002 | -5.85 Million USD | -64.29% |
| 2001 | -3.02 Million USD | 64.32% |
| 2000 | -11.45 Million USD | -13702.24% |
| 1999 | 1.58 Million USD | -98.75% |
| 1998 | 5.4 Million USD | 42.51% |
| 1997 | 4.4 Million USD | 72.77% |
| 1996 | 4.7 Million USD | 333.3% |
| 1995 | -600 Thousand USD | 75.0% |
| 1994 | -3.2 Million USD | 44.62% |
| 1993 | -6.2 Million USD | 54.55% |
| 1992 | -14.1 Million USD | -1091.67% |
| 1991 | -100 Thousand USD | -107.14% |
| 1990 | 1.4 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2008 Q3 | -26.81 Thousand USD | 88.74% |
| 2008 Q2 | -238.1 Thousand USD | 30.77% |
| 2008 Q1 | -343.93 Thousand USD | 13.03% |
| 2007 Q2 | -292.37 Thousand USD | -252.38% |
| 2007 Q1 | 191.86 Thousand USD | 148.66% |
| 2007 FY | - USD | 33.53% |
| 2007 Q4 | -395.44 Thousand USD | 47.46% |
| 2007 Q3 | -752.6 Thousand USD | -157.41% |
| 2006 Q3 | -247.18 Thousand USD | 21.27% |
| 2006 FY | - USD | -9.83% |
| 2006 Q1 | -906.97 Thousand USD | -54.92% |
| 2006 Q2 | -313.97 Thousand USD | 65.38% |
| 2006 Q4 | -394.26 Thousand USD | -59.51% |
| 2005 FY | - USD | 52.64% |
| 2005 Q1 | -233.32 Thousand USD | 66.51% |
| 2005 Q2 | -273.39 Thousand USD | -17.18% |
| 2005 Q3 | -444.65 Thousand USD | -62.64% |
| 2005 Q4 | -585.44 Thousand USD | -31.66% |
| 2004 Q3 | -273.67 Thousand USD | 2.45% |
| 2004 Q2 | -280.54 Thousand USD | 87.99% |
| 2004 Q4 | -696.78 Thousand USD | -154.6% |
| 2004 FY | - USD | 36.43% |
| 2004 Q1 | -2.33 Million USD | -1486.37% |
| 2003 Q3 | 14.87 Thousand USD | 99.82% |
| 2003 FY | - USD | -9.9% |
| 2003 Q1 | -525.24 Thousand USD | 79.33% |
| 2003 Q2 | -799.41 Thousand USD | -701.97% |
| 2003 Q4 | -2.42 Million USD | -1550.48% |
| 2002 Q2 | -1.61 Million USD | -21.51% |
| 2002 Q3 | -716.89 Thousand USD | 2.83% |
| 2002 Q4 | -2.89 Million USD | -286.32% |
| 2002 FY | - USD | -64.29% |
| 2002 Q1 | -638.65 Thousand USD | 65.37% |
| 2001 Q1 | 372.05 Thousand USD | 103.73% |
| 2001 Q3 | -1.01 Million USD | -102.54% |
| 2001 FY | - USD | 64.32% |
| 2001 Q2 | -529.54 Thousand USD | -252.8% |
| 2001 Q4 | -1.85 Million USD | -72.79% |
| 2000 Q3 | 469.47 Thousand USD | -38.66% |
| 2000 FY | - USD | -13702.24% |
| 2000 Q4 | -9.4 Million USD | -2337.28% |
| 2000 Q2 | 719.18 Thousand USD | 219.45% |
| 2000 Q1 | -547.45 Thousand USD | 12.98% |
| 1999 Q4 | 214.33 Thousand USD | 8.64% |
| 1999 Q1 | 505.25 Thousand USD | -60.61% |
| 1999 Q2 | 383.02 Thousand USD | 56.69% |
| 1999 Q3 | -181.06 Thousand USD | -159.05% |
| 1999 FY | - USD | -98.75% |
| 1998 Q4 | 1.99 Million USD | 117.02% |
| 1998 FY | - USD | 42.51% |
| 1998 Q2 | 1.27 Million USD | 43.31% |
| 1998 Q3 | 1 Million USD | -25.51% |
| 1998 Q1 | 1 Million USD | -35.6% |
| 1997 Q1 | 1.14 Million USD | 343.68% |
| 1997 FY | - USD | 72.77% |
| 1997 Q4 | 1.42 Million USD | 226.34% |
| 1997 Q3 | 415.88 Thousand USD | -46.62% |
| 1997 Q2 | 1.22 Million USD | -32.53% |
| 1996 Q4 | 1.66 Million USD | -144.72% |
| 1996 FY | - USD | 333.3% |
| 1996 Q3 | 1.03 Million USD | 19.71% |
| 1996 Q1 | 600 Thousand USD | 220.0% |
| 1996 Q2 | 800 Thousand USD | 44.36% |
| 1995 Q4 | -500 Thousand USD | 28.57% |
| 1995 FY | - USD | 75.0% |
| 1995 Q3 | -700 Thousand USD | -275.0% |
| 1995 Q2 | 500 Thousand USD | 300.0% |
| 1995 Q1 | 300 Thousand USD | 106.67% |
| 1994 FY | - USD | 44.62% |
| 1994 Q2 | -300 Thousand USD | -200.0% |
| 1994 Q4 | -1.3 Million USD | 11.76% |
| 1994 Q3 | -1.5 Million USD | -466.67% |
| 1994 Q1 | -100 Thousand USD | 96.97% |
| 1993 Q2 | -1 Million USD | -42.86% |
| 1993 Q1 | -500 Thousand USD | 84.44% |
| 1993 FY | - USD | 54.55% |
| 1993 Q4 | -3.3 Million USD | -120.0% |
| 1993 Q3 | -1.5 Million USD | -50.0% |
| 1992 FY | - USD | -1091.67% |
| 1992 Q2 | -3 Million USD | -14.81% |
| 1992 Q3 | -3.9 Million USD | -25.81% |
| 1992 Q1 | -2.5 Million USD | 40.0% |
| 1992 Q4 | -4.7 Million USD | -15.38% |
| 1991 Q3 | 1.2 Million USD | -33.33% |
| 1991 Q4 | -4 Million USD | -662.5% |
| 1991 Q1 | 1.4 Million USD | 115.85% |
| 1991 Q2 | 1.2 Million USD | -7.69% |
| 1991 FY | - USD | -185.71% |
| 1990 Q4 | -8.2 Million USD | -356.25% |
| 1990 FY | - USD | 0.0% |
| 1990 Q1 | 3.2 Million USD | 0.0% |
| 1990 Q2 | 3.2 Million USD | 0.0% |
| 1990 Q3 | 3.2 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ansell Limited | 209.86 Million USD | 100.459% |
| Ansell Limited | 206.3 Million USD | 100.467% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 102.25% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 40.678% |
| Psykey, Inc. | -1.29 Million USD | 25.581% |
| ConvaTec Group Plc | 455.5 Million USD | 100.212% |
| ConvaTec Group Plc | 455.5 Million USD | 100.212% |
| Encision Inc. | -544.19 Thousand USD | -77.134% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -579.75% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -776.88% |
| Innovative MedTech Inc. | -7.67 Million USD | 87.438% |
| LifePoint, Inc. | -14.2 Million USD | 93.213% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 84.42% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | -196.601% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | -347.863% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | -137.553% |
| SmileDirectClub, Inc. | -186.13 Million USD | 99.482% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.215% |
| SheerVision, Inc. | -110.53 Thousand USD | -772.112% |
| United Health Products, Inc. | -2.5 Million USD | 61.476% |
| Vasamed, Inc. | -4.57 Million USD | 78.927% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 57.361% |
| Yubo International Biotech Limited | -1.17 Million USD | 18.148% |